tiprankstipranks
Advertisement

VUSV - ETF AI Analysis

Compare

Top Page

VUSV

Vanguard Wellington U.S. Value Active ETF (VUSV)

Rating:67Neutral
Price Target:
VUSV, the Vanguard Wellington U.S. Value Active ETF, earns a solid overall rating largely because many of its biggest positions—like Microsoft, Alphabet, Merck, and ASML—show strong financial performance, positive earnings outlooks, and attractive long-term growth drivers in areas such as cloud, AI, and healthcare. Some holdings, including Amazon and Morgan Stanley, face issues like premium valuations, leverage, or cash flow challenges, and there are pockets of short-term technical caution, but these risks are balanced by the fund’s diversified mix across technology, healthcare, energy, and financials rather than heavy concentration in a single sector.
Positive Factors
Balanced Sector Mix
The fund spreads its investments across many sectors like financials, technology, health care, and industrials, which helps reduce the impact if any one industry struggles.
Several Strong-Performing Holdings
Some key positions such as Merck, Schlumberger, ASML, Chubb, and Dover have shown strong or steady performance, helping offset weaker names in the portfolio.
Moderate Expense Ratio for Active Management
The ETF’s fee is relatively modest for an actively managed strategy, which helps investors keep more of any returns over time.
Negative Factors
Recent Weak Performance
The fund has shown weak returns over the past month and year-to-date, which may concern investors looking for near-term strength.
Underperforming Mega-Cap Tech Holdings
Several of the largest technology-related holdings, including Amazon, Microsoft, and Alphabet, have recently lagged, putting pressure on overall results.
Heavy U.S. Concentration
With almost all assets in U.S. companies and very little overseas exposure, the fund is highly tied to the health of the U.S. market.

VUSV vs. SPDR S&P 500 ETF (SPY)

VUSV Summary

Vanguard Wellington U.S. Value Active ETF (VUSV) is an actively managed fund that invests mainly in U.S. companies the managers believe are undervalued based on their business results. It doesn’t track a fixed index, but focuses on the total U.S. stock market with a value theme across many sectors like financials, technology, and health care. Well-known holdings include Amazon and Microsoft. Someone might invest in VUSV for long-term growth and diversification while focusing on stocks that may be priced lower than their potential. A key risk is that these value stocks can still fall in price and move up and down with the overall market.
How much will it cost me?The Vanguard Wellington U.S. Value Active ETF (VUSV) has an expense ratio of 0.30%, meaning you’ll pay $3 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, which involves more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?The Vanguard Wellington U.S. Value Active ETF (VUSV) could benefit from a strong U.S. economy, as its focus on undervalued companies across sectors like financials, healthcare, and technology may lead to growth opportunities. However, rising interest rates or economic slowdowns could negatively impact its financial and industrial holdings, while regulatory changes in healthcare or technology might also pose risks. Its active management approach provides flexibility to adapt to market changes, but it may underperform if value stocks fall out of favor.

VUSV Top 10 Holdings

VUSV is leaning on a mix of Big Tech and classic value names, but the tech engines are sputtering a bit. Microsoft and Amazon, both sizable positions, have been lagging lately, so they’re not giving the fund the usual mega-cap lift. Alphabet looks steadier, with a more upbeat tone around its AI and cloud story. On the value side, Merck is quietly pulling its weight, while Schlumberger has been a real bright spot as energy stays in favor. Overall, it’s a U.S.-only portfolio with broad sector exposure but notable tilt toward tech, health care, and financials.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Amazon2.90%$1.55M$2.29T25.26%
71
Outperform
Microsoft2.87%$1.54M$2.76T5.00%
79
Outperform
Alphabet Class A2.69%$1.44M$3.69T111.10%
85
Outperform
Merck & Company2.62%$1.40M$294.91B51.08%
80
Outperform
Schlumberger2.27%$1.22M$75.29B57.59%
75
Outperform
Chubb2.22%$1.19M$127.74B19.06%
80
Outperform
ASML Holding2.00%$1.07M$497.09B119.43%
81
Outperform
Dover1.79%$958.54K$27.99B37.32%
79
Outperform
Morgan Stanley1.70%$910.41K$267.44B67.91%
76
Outperform
Raymond James Financial1.70%$908.79K$28.06B14.03%
76
Outperform

VUSV Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
64.03
Negative
100DMA
200DMA
Market Momentum
MACD
-0.44
Negative
RSI
49.43
Neutral
STOCH
93.19
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VUSV, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 62.39, equal to the 50-day MA of 64.03, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.44 indicates Negative momentum. The RSI at 49.43 is Neutral, neither overbought nor oversold. The STOCH value of 93.19 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for VUSV.

VUSV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$54.46M0.30%
67
Neutral
$95.84M0.91%
74
Outperform
$95.54M0.65%
71
Outperform
$78.70M0.50%
73
Outperform
$38.08M0.87%
57
Neutral
$36.71M0.45%
73
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
VUSV
Vanguard Wellington U.S. Value Active ETF
62.86
3.61
6.09%
BAMV
Brookstone Value Stock ETF
YALL
God Bless America ETF
GMOV
GMO US Value ETF
CVAR
Cultivar ETF
GVLE
Goldman Sachs Value Opportunities ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement